SynsoryBio
YC W24Boston, US · Founded 2023 · 2 employees · 1 known investors
SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.
Founders & leadership· Y Combinator alumni (W24)
Elliot TagueinFounder
Nathan TagueinFounder
Investors · 1
In the news
- SynsoryBio - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2024
- SynsoryBio - 2025 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2024